Insulin aspart, recombinant Subcutaneous and Insulin glulisine
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Insulin glulisine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Insulin aspart, recombinant Subcutaneous-Insulin Glulisine (Vials)
- Insulin aspart, recombinant Subcutaneous-Insulin glulisine Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Insulin human inhaled Inhalation
- Insulin aspart, recombinant Subcutaneous-Insulin human regular Injection
- Insulin aspart, recombinant Subcutaneous-Insulin inhalation
- Insulin glulisine-Insulin degludec
- Insulin glulisine-Insulin Degludec (U-100) Prefilled Pens
- Insulin glulisine-Insulin Degludec (U-100) Vials
- Insulin glulisine-Insulin Degludec (U-200) Prefilled Pens
- Insulin glulisine-Insulin degludec and liraglutide
- Insulin glulisine-Insulin degludec and liraglutide Subcutaneous